Targeting CD157 in AML using a novel, Fc-engineered antibody construct

Krupka, C; Lichtenegger, FS; Kohnke, T; Bogeholz, J; Bucklein, V; Roiss, M; Altmann, T; Do, TU; Dusek, R; Wilson, K; Bisht, A; Terrett, J; Aud, D; Pombo-Villar, E; Rohlff, C; Hiddemann, W; Subklewe, M

Subklewe, M (reprint author), Klinikum LMU Munich, Dept Internal Med 3, Munich, Germany.; Subklewe, M (reprint author), Helmholtz Inst Munich, Clin Cooperat Grp Immunotherapy, Munich, Germany.; Subklewe, M (reprint author), Ludwig Maximilians Univ Munchen

ONCOTARGET, 2017; 8 (22): 35707

Abstract

Antibody-based immunotherapy represents a promising strategy to eliminate chemorefractory leukemic cells in acute myeloid leukemia (AML). In this stud......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索